NeoMend Garners $30,000,000 New Financing Round

  • Feed Type
  • Date
    1/27/2010
  • Company Name
    NeoMend
  • Mailing Address
    60 Technology Drive Irvine, CA 92618
  • Company Description
    NeoMend, Inc. is a privately held, clinical stage biomedical device company engaged in the development and commercialization of advanced surgical wound healing products.
  • Website
    http://www.neomendinc.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $30,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    This new funding will move Neomend toward cash flow break-even, as we also pursue approvals for other applications of ProGEL.
  • M&A Terms
  • Venture Investor
    Clarus Ventures
  • Venture Investor
    Novo A/S
  • Venture Investor
    Vivo Ventures
  • Venture Investor
    Sanderling Ventures
  • Venture Investor
    Prospect Venture Partners

By posting a comment, you agree to our terms and conditions.